OKYO Pharma
validation efficacy in dry eye mouse model | OKYO Pharma
Company
Deck Type
Sector
Industry
Deck date
June 2023
Slide
13 of 25
Related slides by other companies
Recursion Pharmaceuticals
Investor Day
January 2023
clinical efficacy found in in mice models led to significant progression free survival further confidence preclinical studies confirming insight | Recursion Pharmaceuticals
Fusion Pharmaceuticals
IPO
June 2020
enhanced efficacy in a mouse tumor model | Fusion Pharmaceuticals
Bausch+Lomb
Results
May 2023
building a global dynamic dry eye disease platform dry eye total revenue for | Bausch+Lomb
Arbutus Biopharma
Investor Presentation
August 2023
reduces in mouse model | Arbutus Biopharma
Other recent decks by OKYO Pharma
See all presentations (2 decks)
Shareholder Engagement
March 2020
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io